Abbott India has announced that a meeting of its Board of Directors is scheduled for November 6, 2025. The primary agenda is to review and approve the unaudited financial results for the quarter and half-year ending September 30, 2025. The trading window for the company’s shares remains closed from October 1, 2025, until November 8, 2025.
Board Meeting Announcement
Abbott India has scheduled a meeting of its Board of Directors to be held on November 6, 2025. The board will deliberate on and approve the unaudited financial results for the quarter and half-year which ended on September 30, 2025.
Trading Window Closure
In accordance with Abbott India’s internal code of conduct and regulations regarding insider trading, the trading window for company shares remains closed. The closure period extends from October 1, 2025, to November 8, 2025. This restriction applies to designated persons and their immediate relatives as defined under the regulations.
Source: BSE